Review



anti fasl  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Santa Cruz Biotechnology anti fasl
    Anti Fasl, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 684 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fas+l/FAS-L+Antibody/pm41796629-94-16-18
    Average 94 stars, based on 684 article reviews
    anti fasl - by Bioz Stars, 2026-09
    94/100 stars

    Images

    Related Articles

    Expressing:

    Article Title: Tumor Microenvironment‐Selective Sol–Gel Mineralization of ROS‐Responsive Stretchable and Conductive Hydrogel
    Article Snippet: Cancer cell-triggered sol–gel transformation of mineralized hydrogel (PAA-MnO2) is designed as a facile strategy for cancer detection by manipulating the mineralization process in the presence of cancer cells.. The mineralization of polyacrylic acid (PAA) with calcium phosphate via carboxyl-Ca2+ complex is initially inhibited by the incorporation of reactive oxygen species (ROS)-sensitive manganese oxide (MnO2) with polymer dots (PDs).. In this system, the mineralization can be induced after cleaving MnO2 into Mn2+ by high ROS levels in cancer cells, forming a PAA-MnO2 mineralized hydrogel and resulting in a naked-eye system for cancer monitoring.

    Incubation:

    Article Title: Parthenolide Induces ROS-Mediated Apoptosis in Lymphoid Malignancies.
    Article Snippet: .. A quantity of 1 × 106 cells was incubated with a monoclonal antibody anti-activated caspase 3-fluorescein isothiocyanate (FITC; BD Pharmingen, Becton Dickinson), and FAS-L (PE; Santa Cruz Technology, Dallas, TX, USA) antibodies according to the manufacturer’s protocol. .. For intracellular staining of activated caspase 3, cells were fixed with 100 μL of a fix solution (IntraCell, Immunostep, Salamanca, Spain) for 15 min and then washed by centrifugation at 300× g for 5 min.

    other:

    Article Title: Folic Acid and Folinic Acid Protect Hearts of Aging Triple-transgenic Alzheimer's Disease mice via IGF1R/PI3K/AKT and SIRT1/AMPK Pathways.
    Article Snippet: Patients with Alzheimer's disease have increased risk of developing heart disease, which therefore highlights the need for strategies aiming at reducing Alzheimer's disease-related cardiovascular disease.. Folic acid and folinic acid are beneficial to the heart.. We aimed to investigate the benefits of folic acid and folinic acid in heart of patients with late-stage Alzheimer's disease.



    Similar Products

    93
    Miltenyi Biotec fas l
    Fas L, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fas+l/CD178+Antibody%2C+anti-human%2C+REAfinity/pm42455847-67-65-67
    Average 93 stars, based on 1 article reviews
    fas l - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    94
    MedChemExpress fa 250 mg kg in 0 3 mol l sodium bicarbonate
    Fa 250 Mg Kg In 0 3 Mol L Sodium Bicarbonate, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fas+l/Sodium+bicarbonate/pm41963952-74-17-25
    Average 94 stars, based on 1 article reviews
    fa 250 mg kg in 0 3 mol l sodium bicarbonate - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    86
    Photonics Inc mcfbt 12 1550 50 00 16 s2 08 l fa dk
    Mcfbt 12 1550 50 00 16 S2 08 L Fa Dk, supplied by Photonics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fas+l/00+10+1550+dk+fa+l+mcvoa+s2/pm41894489-217-2-13
    Average 86 stars, based on 1 article reviews
    mcfbt 12 1550 50 00 16 s2 08 l fa dk - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    86
    Photonics Inc mcvoa 1550 00 s2 10 l fa dk
    Mcvoa 1550 00 S2 10 L Fa Dk, supplied by Photonics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fas+l/00+10+1550+dk+fa+l+mcvoa+s2/pmc13025021-195-11-13
    Average 86 stars, based on 1 article reviews
    mcvoa 1550 00 s2 10 l fa dk - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology anti fasl
    Anti Fasl, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fas+l/FAS-L+Antibody/pm41796629-94-16-18
    Average 94 stars, based on 1 article reviews
    anti fasl - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology fasl antibody
    Therapy-induced senescence in tumor spheroids impairs the viability of infiltrated immune cells. (A) Schematic representation of the 3D tumor spheroid model. In brief, A549 tumor cells alone or with an equal number of HDF (5000 cells for each) were mixed to form monospheroids or mixed-cell spheroids, respectively. Five days after, spheroids were treated with doxorubicin (0.1µM) or irradiated (15 Gy) to induce senescence. Then, four days later PBMCs (5 x 10 5 ) were added, and their infiltration into the spheroid was quantified 48 hours later by flow cytometry. (B) Representative images of spheroids stained for β-galactosidase activity six days after being treated with doxorubicin or irradiation. Unstained spheroids or spheroids not exposed to therapy were used as controls. The scale bar represents 100 μm. (C) Graph showing the average size of spheroids represented by the largest brightfield object area metric (µm 2 ) over time following treatments as detected by IncuCyte imaging. Shown is the mean ± SEM of three independent experiments. Statistical differences were identified by mixed-effects modeling with Tukey’s multiple comparisons. ****p < 0.0001. (D) Representative images of immunostained spheroid sections showing CD45 + immune cell infiltration (white), the presence of HDF (GFP, green), <t>FasL</t> expression (red), and cell nuclei (DAPI, blue). Scale bar = 100 μm. (E) Graph showing the proportion of live (Annexin V - /PI - ) CD45 + immune cells infiltrated in spheroids from the indicated groups. Each dot represents the average of infiltrated cells in n=6 spheroids collected from four independent experiments. Shown is the mean ± SEM. Statistical analysis between groups was performed by a one-way ANOVA with Tukey’s multiple comparisons. *p < 0.05. (F) Schematic of the in vivo experimental design. NSG-SGM3 mice were injected intravenously (i.v) with 4X10 5 non-senescent HDF. After 29 days mice received a single dose of whole thorax radiation (12Gy). Seven days after, mice were sacrificed, and lungs were collected for analysis. (G) Representative <t>immunofluorescence</t> <t>staining</t> of HDF (GFP in green), FasL (in red), and cell nuclei (DAPI in blue) from irradiated and non-irradiated lung tissues. The scale bar represents 100 μm. (H) Confocal images shown at higher magnification of a tissue section as described in (G) .
    Fasl Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fas+l/FAS-L+Antibody/pmc12597918-171-22-26
    Average 94 stars, based on 1 article reviews
    fasl antibody - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology fas l antibody
    Therapy-induced senescence in tumor spheroids impairs the viability of infiltrated immune cells. (A) Schematic representation of the 3D tumor spheroid model. In brief, A549 tumor cells alone or with an equal number of HDF (5000 cells for each) were mixed to form monospheroids or mixed-cell spheroids, respectively. Five days after, spheroids were treated with doxorubicin (0.1µM) or irradiated (15 Gy) to induce senescence. Then, four days later PBMCs (5 x 10 5 ) were added, and their infiltration into the spheroid was quantified 48 hours later by flow cytometry. (B) Representative images of spheroids stained for β-galactosidase activity six days after being treated with doxorubicin or irradiation. Unstained spheroids or spheroids not exposed to therapy were used as controls. The scale bar represents 100 μm. (C) Graph showing the average size of spheroids represented by the largest brightfield object area metric (µm 2 ) over time following treatments as detected by IncuCyte imaging. Shown is the mean ± SEM of three independent experiments. Statistical differences were identified by mixed-effects modeling with Tukey’s multiple comparisons. ****p < 0.0001. (D) Representative images of immunostained spheroid sections showing CD45 + immune cell infiltration (white), the presence of HDF (GFP, green), <t>FasL</t> expression (red), and cell nuclei (DAPI, blue). Scale bar = 100 μm. (E) Graph showing the proportion of live (Annexin V - /PI - ) CD45 + immune cells infiltrated in spheroids from the indicated groups. Each dot represents the average of infiltrated cells in n=6 spheroids collected from four independent experiments. Shown is the mean ± SEM. Statistical analysis between groups was performed by a one-way ANOVA with Tukey’s multiple comparisons. *p < 0.05. (F) Schematic of the in vivo experimental design. NSG-SGM3 mice were injected intravenously (i.v) with 4X10 5 non-senescent HDF. After 29 days mice received a single dose of whole thorax radiation (12Gy). Seven days after, mice were sacrificed, and lungs were collected for analysis. (G) Representative <t>immunofluorescence</t> <t>staining</t> of HDF (GFP in green), FasL (in red), and cell nuclei (DAPI in blue) from irradiated and non-irradiated lung tissues. The scale bar represents 100 μm. (H) Confocal images shown at higher magnification of a tissue section as described in (G) .
    Fas L Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/fas+l/FAS-L+Antibody/pmc12597918-195-17-21
    Average 94 stars, based on 1 article reviews
    fas l antibody - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    Image Search Results


    Therapy-induced senescence in tumor spheroids impairs the viability of infiltrated immune cells. (A) Schematic representation of the 3D tumor spheroid model. In brief, A549 tumor cells alone or with an equal number of HDF (5000 cells for each) were mixed to form monospheroids or mixed-cell spheroids, respectively. Five days after, spheroids were treated with doxorubicin (0.1µM) or irradiated (15 Gy) to induce senescence. Then, four days later PBMCs (5 x 10 5 ) were added, and their infiltration into the spheroid was quantified 48 hours later by flow cytometry. (B) Representative images of spheroids stained for β-galactosidase activity six days after being treated with doxorubicin or irradiation. Unstained spheroids or spheroids not exposed to therapy were used as controls. The scale bar represents 100 μm. (C) Graph showing the average size of spheroids represented by the largest brightfield object area metric (µm 2 ) over time following treatments as detected by IncuCyte imaging. Shown is the mean ± SEM of three independent experiments. Statistical differences were identified by mixed-effects modeling with Tukey’s multiple comparisons. ****p < 0.0001. (D) Representative images of immunostained spheroid sections showing CD45 + immune cell infiltration (white), the presence of HDF (GFP, green), FasL expression (red), and cell nuclei (DAPI, blue). Scale bar = 100 μm. (E) Graph showing the proportion of live (Annexin V - /PI - ) CD45 + immune cells infiltrated in spheroids from the indicated groups. Each dot represents the average of infiltrated cells in n=6 spheroids collected from four independent experiments. Shown is the mean ± SEM. Statistical analysis between groups was performed by a one-way ANOVA with Tukey’s multiple comparisons. *p < 0.05. (F) Schematic of the in vivo experimental design. NSG-SGM3 mice were injected intravenously (i.v) with 4X10 5 non-senescent HDF. After 29 days mice received a single dose of whole thorax radiation (12Gy). Seven days after, mice were sacrificed, and lungs were collected for analysis. (G) Representative immunofluorescence staining of HDF (GFP in green), FasL (in red), and cell nuclei (DAPI in blue) from irradiated and non-irradiated lung tissues. The scale bar represents 100 μm. (H) Confocal images shown at higher magnification of a tissue section as described in (G) .

    Journal: Frontiers in Immunology

    Article Title: Senescent human fibroblasts have increased FasL expression and impair the tumor immune response

    doi: 10.3389/fimmu.2025.1685269

    Figure Lengend Snippet: Therapy-induced senescence in tumor spheroids impairs the viability of infiltrated immune cells. (A) Schematic representation of the 3D tumor spheroid model. In brief, A549 tumor cells alone or with an equal number of HDF (5000 cells for each) were mixed to form monospheroids or mixed-cell spheroids, respectively. Five days after, spheroids were treated with doxorubicin (0.1µM) or irradiated (15 Gy) to induce senescence. Then, four days later PBMCs (5 x 10 5 ) were added, and their infiltration into the spheroid was quantified 48 hours later by flow cytometry. (B) Representative images of spheroids stained for β-galactosidase activity six days after being treated with doxorubicin or irradiation. Unstained spheroids or spheroids not exposed to therapy were used as controls. The scale bar represents 100 μm. (C) Graph showing the average size of spheroids represented by the largest brightfield object area metric (µm 2 ) over time following treatments as detected by IncuCyte imaging. Shown is the mean ± SEM of three independent experiments. Statistical differences were identified by mixed-effects modeling with Tukey’s multiple comparisons. ****p < 0.0001. (D) Representative images of immunostained spheroid sections showing CD45 + immune cell infiltration (white), the presence of HDF (GFP, green), FasL expression (red), and cell nuclei (DAPI, blue). Scale bar = 100 μm. (E) Graph showing the proportion of live (Annexin V - /PI - ) CD45 + immune cells infiltrated in spheroids from the indicated groups. Each dot represents the average of infiltrated cells in n=6 spheroids collected from four independent experiments. Shown is the mean ± SEM. Statistical analysis between groups was performed by a one-way ANOVA with Tukey’s multiple comparisons. *p < 0.05. (F) Schematic of the in vivo experimental design. NSG-SGM3 mice were injected intravenously (i.v) with 4X10 5 non-senescent HDF. After 29 days mice received a single dose of whole thorax radiation (12Gy). Seven days after, mice were sacrificed, and lungs were collected for analysis. (G) Representative immunofluorescence staining of HDF (GFP in green), FasL (in red), and cell nuclei (DAPI in blue) from irradiated and non-irradiated lung tissues. The scale bar represents 100 μm. (H) Confocal images shown at higher magnification of a tissue section as described in (G) .

    Article Snippet: Sections were mounted on gelatin-coated slides and subjected to immunofluorescence staining using a GFP polyclonal antibody (A-11122; Thermo Fisher Scientific, USA), a FasL antibody (NOK-1, sc-33716; Santa Cruz Biotechnology), and DAPI for nuclear counterstaining.

    Techniques: Irradiation, Flow Cytometry, Staining, Activity Assay, Imaging, Expressing, In Vivo, Injection, Immunofluorescence